Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen–Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia-Reference-Cited by-同舟云学术

Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen–Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia

Published:2016-11 Issue:11 Volume:22 Page:2065-2076
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Choi Inpyo,Yoon Suk Ran,Park Soo-Yeon,Kim Hanna,Jung Sol-Ji,Kang You-Lee,Lee Je-Hwan,Lee Jung-Hee,Kim Dae-Young,Lee Jae-Lyun,Park Han-Seung,Choi Eun-Ji,Lee Young-Shin,Kang Young-A.,Jeon Mijin,Seol Miee,Baek Seunghyun,Yun Sung-Cheol,Kim Hwa Jung,Lee Kyoo-Hyung

Funder

Ministry of Health and Welfare

R&D Convergence Program of National Research Council of Science & Technology

Ministry of Education, Science and Technology

KRIBB Research Initiative Program

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference52 articles.

1. Treatment of relapsed and refractory acute myelogenous leukemia;Estey;Leukemia,2000

2. Response to salvage therapy and survival after relapse in acute myelogenous leukemia;Keating;J Clin Oncol,1989